Petros Pharmaceuticals, Inc. (PTPI) › RevenuePetros Pharmaceuticals, Inc. (PTPI) — RevenueAnnual figures by period end, from SEC filings.2020-12-31: $9.56M2021-12-31: $7.81M2022-12-31: $5.99M2023-12-31: $5.82M2024-12-31: $5.11M$5.11M2020-12-31Revenue (USD)2024-12-31Period endedRevenueChange YoYSource filing2024-12-31$5.11M-12.2%2025-03-31From 2024-01-012023-12-31$5.82M-2.8%2025-03-31From 2023-01-012022-12-31$5.99M-23.3%2024-04-01From 2022-01-012021-12-31$7.81M-18.3%2023-03-31From 2021-01-012020-12-31$9.56M—2022-03-31From 2020-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)